Search ARM

Publications & Presentations


ARM fosters investment, research & development, commercialization, and access to safe, effective, and transformational treatments and cures.


ARM fosters investment, research & development, commercialization, and access to safe, effective, and transformational treatments and cures.

ARM Commentary

January 16, 2021
MedNous

A Record Year for the Financings of ATMPs

September 14, 2020
Op-Ed

Regenerative medicine will require innovative ways to pay

July 27, 2020
Op-Ed

Why We Need A New Model To Appropriately Value The Promise Of Regenerative Medicines & Advanced Therapies

June 18, 2020

A Wave of New Technology: Gene-Edited Therapies Produce First Clinical Data

May 5, 2020

Creating A Roadmap For The Development And Manufacture Of Gene Therapies

February 28, 2020

Bringing Regenerative Medicines to Patients in Need

January 31, 2020
Cell & Gene Therapy Insights

State of the Industry: The Financial, Clinical, and Scientific Landscape for Cell and Gene Therapies

June 10, 2019
In Vivo

Manufacturing Cures: Infrastructure Challenges Facing Cell And Gene Therapy Developers

May 13, 2019

Update on Regenerative Medicine Advanced Therapies Designations

Sector Presentations

January 10, 2022

2022 State of the Industry

Virtual

Janet Lambert, CEO, ARM

This event included ARM’s annual yearly update on the sector’s progress followed by two panel sessions featuring top executives highlighting future inflection points for cell and gene therapies.

September 23, 2021

Cell & Gene Therapy Manufacturing & Commercialization

Virtual

Janet Lambert, CEO, ARM

This presentation provided a mid-year update on the cell and gene therapy industry with a focus on manufacturing considerations.

September 9, 2021

Academy of Managed Care Pharmacy Webinar

Virtual

Stephen Majors, Director, Public Affairs

This webinar provided an introduction to cell and gene therapies, as well as a look at the investment and clinical landscape.

June 7, 2021

CASSS Cell & Gene Therapy Products 2021 Keynote

Virtual

Janet Lambert, CEO, ARM

This presentation provides an overview of the investment, clinical, and scientific environment for cell and gene therapies.

April 26, 2021

ATMP World Tour

Virtual

Stephen Majors, Director, Public Affairs

This presentation provides an overview of ARM’s mission and the benefits of ARM membership.

March 10, 2021

PartnerRe Webinar: Preparing for the Gene & Cell Therapy Wave

Virtual

Stephen Major, Director, Public Affairs

This presentation provides an overview of the cell & gene therapy landscape with a focus on multiple myeloma.

February 24, 2021

Gene Therapy for Rare Disorders

Virtual

Janet Lambert, CEO, ARM

This presentation looks at the investment and clinical landscape for gene therapy for rare disorders.

January 13, 2021

Cell & Gene State of the Industry

Virtual

Janet Lambert, CEO, ARM

This presentation identifies major milestones in the gene therapy and cell therapy field over the past year and provides an overview of the financial, clinical, and policy environment.

October 21, 2020

Ausbiotech + Invest 2020

Virtual

Janet Lambert, CEO, ARM

On overview of investment considerations for the cell & gene therapy sector.

May 11, 2020

Valuing Transformative Therapies

Virtual

Janet Lambert, CEO, ARM

The presentation, which provides an overview on value demonstration for cell and gene therapies, cites information from ARM’s library of original policy analyses.

February 27, 2020

Landscape and Evolution of the Cell & Gene Therapy Marketplace

New York City

Janet Lambert, CEO, ARM

The presentation, which provides an overview of public policy considerations for the cell and gene therapy sector, cites information from ARM’s library of original policy analyses.

February 26, 2020

CAR-TCR Europe 2020: ATMP Market Access

London

Annie Hubert, Sr. Director, European Policy, ARM

This presentation draws on conclusions from ARM’s 2020 position paper on providing cross-border access to ATMPs in Europe, available here.

February 25, 2020

CMC for CAR-T Therapies

London

Michael Lehmicke, Director, Science & Industry Affairs, ARM

Additional information on ARM’s manufacturing initiatives is available here.

February 25, 2020

Cell and Gene Therapy Workshop

New York City

Robert Falb, Director, US Policy & Advocacy, ARM

The presentation provides an overview of the cell and gene therapy sector, with an emphasis on CAR-T therapies and related policy provisions.

February 7, 2020

ATMPs in Europe: State of Play

Berlin, Germany

Annie Hubert, Sr. Director, European Policy, ARM

This presentation provides an overview of the European ATMP sector, including financings, clinical development, and ARM’s European policy priorities.

January 22, 2020

Regenerative Medicine Sector Overview

Miami, FL

Janet Lambert, CEO, ARM

This presentation, which includes data from ARM’s 2019 Global Sector Report, provides an overview of the regenerative medicine and advanced therapy sector for conference attendees.

January 13, 2020

Cell & Gene State of the Industry 2020

San Francisco, CA

Janet Lambert, CEO, ARM

ARM’s annual State of the Industry briefing provides an update on global financings, clinical development, public policy considerations, and other regenerative medicine sector trends. A recording of the presentation is available here.

December 12, 2019

Getting Ready: EU ATMP Access Event

Brussels, Belgium

Janet Lambert, CEO, ARM

This roundtable event brought together sector stakeholders to discuss improved patient access to ATMPs in Europe. The presentation included an overview of ARM’s Getting Ready report.

October 29, 2019

ICMRA October 2019 Meeting

Rome, Italy

Janet Lambert, CEO, ARM & Michael Werner, Sr. Policy Counsel, ARM

ARM provided an overview of regulatory considerations in the US, Europe, and abroad for the International Coalition of Medicines Regulatory Authorities.

October 15, 2019

Advanced Therapies Sector Overview

London, UK

Annie Hubert, Sr. Director, European Policy, ARM

The presentation included an overview of the financial and clinical landscape for the development of gene therapies for rare disorders and policy priorities to promote development and patient access.

October 10, 2019

Gene Therapies: Sector Overview

New York City

Janet Lambert, CEO, ARM

ARM provided an overview of the gene therapy sector for the New York Academy of Sciences, including the clinical landscape for innovative gene-editing technologies.

October 3, 2019

ARM's Role in the Sector

Carlsbad, CA

Janet Lambert, CEO, ARM

This presentation provides an overview of ARM to attendees at the annual Meeting on the Mesa. For more information on the Meeting on the Mesa, click here. A recording of the remarks is available here.

October 2, 2019

Welcome to the Meeting on the Mesa

Carlsbad, CA

Janet Lambert, CEO, ARM

ARM CEO Janet Lambert  annual Meeting on the Mesa. For more information on the Meeting on the Mesa, click here. A recording of the presentation is available here.

September 12, 2019

Cell & Gene Therapy Bioprocessing & Commercialization 2019

Boston, MA
September 12, 2019

Cross-Sector Efforts to Advance Cell & Gene Therapy Manufacturing

Boston, MA
August 27, 2019

Principles for Ethical Application of Gene Editing in the Clinic

Geneva, Switzerland
July 15, 2019

Regenerative Medicine Sector Overview

Boston, MA

Webinar & Video Library

January 13, 2022

Comparability

This webinar provides guidance to sponsors and developers on the best practices and recommendations in managing manufacturing changes during early development.

October 28, 2021

Drug Product

This webinar discusses the vector manufacturing process and how it culminates with the formulation and vialing of the purified vector product.

July 28, 2021

Process Control Strategy

This webinar discusses how a comprehensive control strategy for pharmaceutical products – including gene therapies – is the key to achieving process consistency, product quality, safety, and efficacy.

ARM provides a library of recordings of panels, company presentations, webinars, and more on our YouTube page.

 

YouTube All Videos & Recordings